Evaluation of the thyroid nodule

Cancer Control

Volumn 13, Issue 2, 2006, Pages 89-98

  Lansford, Christopher D ^a   Teknos, Theodoros N ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOACTIVE IODINE; TECHNETIUM 99M;

ACCURACY; ALGORITHM; ANAMNESIS; ASPIRATION BIOPSY; BIOCHEMISTRY; CANCER RISK; CANCER SURGERY; COST EFFECTIVENESS ANALYSIS; CYTOPATHOLOGY; DIAGNOSTIC PROCEDURE; GENETIC ANALYSIS; HUMAN; IMAGING; MEDICAL LITERATURE; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; REVIEW; RISK ASSESSMENT; SCINTISCANNING; SEROLOGY; SURGICAL TECHNIQUE; THYROID CARCINOMA; THYROID NODULE; THYROID SURGERY; TREATMENT INDICATION;

EID: 33745220080     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327480601300202     Document Type: Review

References (68)

1. Salabe GB. Pathogenesis of thyroid nodules: histologic classification? Biomed Pharmacother. 2001;55:39-53.
2. Castro MR, Gharib H. Thyroid nodules and cancer: when to wait and watch, when to refer. Postgrad Med. 2000;107:113-124.
3. Mazzaferri EL. Thyroid cancer in thyroid nodules: finding a needle in the haystack. Am J Med. 1992;93:359-362.
4. Singer PA, Cooper DS, Daniels GH, et al. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med. 1996;156: 2165-2172.
5. Wong CK, Wheeler MH. Thyroid nodules: rational management. World J Surg. 2000;24:934-941.
6. Meko JB, Norton JA. Large cystic/solid thyroid nodules: a potential false-negative fine-needle aspiration. Surgery. 1995;118: 996-1004.
7. Brander A, Viikinkoski P, Nickels J, et al. Thyroid gland: US screening in a random adult population. Radiology. 1991;181:683-687.
8. Tan GH, Gharib H, Reading CC. Solitary thyroid nodule. Comparison between palpation and ultrasonography. Arch Intern Med. 1995;155:2418-2423.
9. Burguera B, Gharib H. Thyroid incidentalomas. Prevalence, diagnosis, significance, and management. Endocrinol Metab Clin North Am. 2000;29:187-203.
10. McCall A, Jarosz H, Lawrence AM, et al. The incidence of thyroid carcinoma in solitary cold nodules and in multinodular goiters. Surgery. 1986;100:1128-1132.
11. Blum M, Hussain MA. Evidence and thoughts about thyroid nodules that grow after they have been identified as benign by aspiration cytology. Thyroid. 2003;13:637-641.
12. Belfiore A, La Rosa GL, La Porta GA, et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med. 93:363-369.
13. Nam-Goong IS, Kim HY, Gong G, et al. Ultrasonography-guided fineneedle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol (Oxf). 2004;60:21-28.
14. Belfiore A, Garofalo MR, Giuffrida D, et al. Increased aggressiveness of thyroid cancer in patients with Graves' disease. J Clin Endocrinol Metab. 1990;70:830-835.
15. de los Santos ET, Keyhani-Rofagha S, Cunningham JJ, et al. Cystic thyroid nodules. The dilemma of malignant lesions. Arch Intern Med. 1990;150:1422-1427.
16. McHenry CR, Slusarczyk SJ, Khiyami A. Recommendations for management of cystic thyroid disease. Surgery. 1999;126: 1167-1172.
17. Hegedüs L. The thyroid nodule. N Engl J Med. 2004;351: 1764-1771.
18. King AD, Ahuja AT, King W, et al. The role of ultrasound in the diagnosis of a large, rapidly growing, thyroid mass. Postgrad Med J. 1997;73:412-414.
19. Hung W. Solitary thyroid nodules in 93 children and adolescents. A 35-years experience. Hormone Research. 1999;52:15-18.
20. Raab SS, Silverman JF, Elsheikh TM, et al. Pediatric thyroid nodules: disease demographics and clinical management as determined by fine needle aspiration biopsy. Pediatrics. 1995; 95:46-49.
21. Black BM, Hayles AB, Kennedy RL, et al. Nodular lesions of the thyroid gland in children. J Clin Endocrinol Metab. 1956;16: 1580-1594.
22. Rallison ML, Dobyns BM, Keating FR, et al. Thyroid nodularity in children. JAMA. 1975;233:1069-1072.
23. Shapiro NL, Bhattacharyya N. Population-based outcomes for pediatric thyroid carcinoma. Laryngoscope. 2005;115:337-340.
24. Harvey HK. Diagnosis in management of the thyroid nodule. An overview. Otolaryngol Clin North Am. 1990;23:303-337.
25. Rojeski MT, Gharib H. Nodular thyroid disease. N Engl J Med. 1985;313:428-436.
26. Hamming JF, Goslings BM, van Steenis GJ, et al. The value of fineneedle aspiration biopsy in patients with nodular thyroid disease divided into groups of suspicion of malignant neoplasm on clinical grounds. Arch Intern Med. 1990;150:113-116. Erratum in: Arch Intern Med. 1990;150:1088.
27. Schlumberger M, Pacini F, eds. Thyroid tumors after external irradiation. In: Thyroid Tumors. 1st ed. Paris: Editions Nucleon; 1999.
28. Hancock SL, McDougall IR, Constine LS. Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys. 1995;31: 1165-1170.
29. Shaha AR. Controversies in the management of thyroid nodule. Laryngoscope. 2000;110:183-193.
30. Maxon HR, Thomas SR, Saenger EL, et al. Ionizing irradiation and the induction of clinically significant disease in the human thyroid gland. Am J Med. 1977;63:967-978.
31. Hansford JR, Mulligan LM. Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J Med Genet. 2000;37:817-827.
32. Ashcraft MW, Van Herle AJ. Management of thyroid nodules. II: Scanning techniques, thyroid suppressive therapy, and fine needle aspiration. Head Neck Surg. 1981;3:297-322.
33. Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med. 1993;328:553-559.
34. Eisele DW, Sherman ME, Koch WM, et al. Utility of immediate onsite cytopathological procurement and evaluation in fine needle aspiration biopsy of head and neck masses. Laryngoscope. 1992;102:1328-1330.
35. Bouvet M, Feldman JI, Gill GN, et al. Surgical management of the thyroid nodule: patient selection based on the results of fine-needle aspiration cytology. Laryngoscope. 1992;102:1353-1356.
36. Leonard N, Melcher DH. To operate or not to operate? The value of fine needle aspiration cytology in the assessment of thyroid swellings. J Clin Path. 1997;50:941-943.
37. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med. 1993;118:282-289.
38. Hamburger JI, Hamburger SW. Declining role of frozen section in surgical planning for thyroid nodules. Surgery. 1985;98: 307-312.
39. Caplan RH, Wester S, Kisken WA. Fine-needle aspiration biopsy of solitary thyroid nodules. Effect on cost of management, frequency of thyroid surgery, and operative yield of thyroid malignancy. Minn Med. 1986;69:189-192.
40. Hamberger B, Gharib H, Melton LJ 3rd, et al. Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med. 1982;73:381-384.
41. Cohen Y, Rosenbaum E, Clark DP, et al. Mutational analysis of BRAF in fine-needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules. Clin Cancer Research. 2004;10:2761-2765.
42. Salvatore G, Giannini R, Faviana P, et al. Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab. 2004;89:5175-5180.
43. Belfiore A, La Rosa GL. Fine-needle aspiration biopsy of the thyroid. Endocrinol Metab Clin North Am. 2001;30:361-400.
44. Lin JD, Huang BY. Comparison of the results of diagnosis and treatment between solid and cystic well-differentiated thyroid carcinomas. Thyroid. 1998;8:661-666.
45. Gharib H, Mazzaferri EL. Thyroxine suppressive therapy in patients with nodular thyroid disease. Ann Intern Med. 1998;128: 386-394.
46. Lippi F, Ferrari C, Manetti L, et al. Treatment of solitary autonomous thyroid nodules by percutaneous ethanol injection: results of an Italian multicenter study. The Multicenter Study Group. J Clin Endocrinol Metab. 1996;81:3261-3264.
47. Zingrillo M, Torlontano M, Ghiggi MR, et al. Percutaneous ethanol injection of large thyroid cystic nodules. Thyroid. 1996;6: 403-408.
48. Lupoli G, Vitale G, Caraglia M. Family papillary thyroid microcarcinoma: a new clinical entity. Lancet. 1999;353:637-639.
49. Hatipoglu BA, Gierlowski T, Shore-Freedman E, et al. Fine-needle aspiration of thyroid nodules in radiation-exposed patients. Thyroid. 2000;10:63-69.
50. Pellegriti G, Belfiore A, Giuffrida D, et al. Outcome of differentiated thyroid cancer in Graves' patients. J Clin Endocrinol Metab. 1998;83:2805-2809.
51. Ashcraft MW, Van Herle AJ. Management of thyroid nodules. I: History and physical examination, blood tests, X-ray tests, and ultrasonography. Head Neck Surg. 1981;3:216-230.
52. Hegedüs L. Thyroid ultrasound. Endocrinol Metab Clin North Am. 2001;30:339-360.
53. Kim EK, Park CS, Chung WY, et al. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AJR Am J Roentgenol. 2002; 178:687-691.
54. Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in non-palpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab. 2002;87:1941-1946.
55. Rago T, Vitti P, Chiovato L, et al. Role of conventional ultrasonography and color flow-doppler sonography in predicting malignancy in 'cold' thyroid nodules. Eur J Endocrinol. 1998;138:41-46.
56. Frates MC, Benson CB, Charboneau JW, et al. Management of thyroid nodules detected at US: Society of Radiologists in ultrasound consensus conference statement. Radiology. 2005;237:794-799.
57. Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid. 2003;13:381-387.
58. Rago T, Vitti P, Chiovato L, et al. Role of conventional ultrasonography and color flow-doppler sonography in predicting malignancy in 'cold' thyroid nodules. Eur J Endocrinol. 1998;138:41-46.
59. Kim N, Lavertu P. Evaluation of a thyroid nodule. Otolaryngol Clin North Am. 2003;36:17-33.
60. McConahey WM, Hay ID, Woolner LB, et al. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc. 1986;61:197-196.
61. Kim TY, Kim WB, Ryu JS, et al. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for Evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope. 2005;115:1074-1078.
62. Donis-Keller H, Dou S, Chi D, et al. Mutations in the RET protooncogene are associated with MEN-2A and FMTC. Hum Mol Genet. 1993;2:851-856.
63. Carlson KM, Dou S, Chi D, et al. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci U S A. 1994;91:1579-1583.
64. Frank-Raue K, Höppner W, Frilling A, et al. Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. J Clin Endocrinol Metab. 1996;81:1780-1783.
65. Machens A, Gimm O, Hinze R, et al. Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties. J Clin Endocrinol Metab. 2001;86:1104-1109.
66. Learoyd DL, Marsh DJ, Richardson AL, et al. Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2. Arch Surg. 1997;132:1022-1025.
67. Takami H. Medullary thyroid carcinoma and multiple endocrine neoplasia type 2. Endocr Pathol. 2003;14:123-131.
68. Machens A, Ukkat J, Brauckhoff M, et al. Advances in the management of hereditary medullary thyroid cancer. J Intern Med. 2005;257:50-59.